BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8267685)

  • 1. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic uptake of iodine-131 in the anterior mediastinum.
    Veronikis IE; Simkin P; Braverman LE
    J Nucl Med; 1996 Jun; 37(6):991-2. PubMed ID: 8683329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine concentration by the thymus in thyroid carcinoma.
    Vermiglio F; Baudin E; Travagli JP; Caillou B; Fragu P; Ricard M; Schlumberger M
    J Nucl Med; 1996 Nov; 37(11):1830-1. PubMed ID: 8917186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymus accumulation of I-131 after therapeutic dose for thyroid carcinoma.
    Muratet JP; Giraud P
    Clin Nucl Med; 1996 Sep; 21(9):736-7. PubMed ID: 8879880
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma.
    Salvatori M; Saletnich I; Rufini V; Troncone L
    Clin Nucl Med; 1997 Jun; 22(6):380-4. PubMed ID: 9193808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights.
    Haghighatafshar M; Farhoudi F
    Medicine (Baltimore); 2015 Jul; 94(26):e1015. PubMed ID: 26131804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases.
    Mello ME; Flamini RC; Corbo R; Mamede M
    Arq Bras Endocrinol Metabol; 2009 Oct; 53(7):874-9. PubMed ID: 19942990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans?
    Davidson J; McDougall IR
    Eur J Nucl Med; 2000 Apr; 27(4):425-30. PubMed ID: 10805116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic uptake after high-dose I-131 treatment in patients with differentiated thyroid carcinoma: a brief review of possible causes and management.
    Arce MB; Molina TC; Hernández TM; de la Cinta Calvo Morón M; Herrero CH; De La Riva Pérez PA; Montaño JC
    Endocrinol Nutr; 2015 Jan; 62(1):19-23. PubMed ID: 25160708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-131 uptake in thymic hyperplasia with atypical computed tomographic features.
    Lin EC
    Clin Nucl Med; 2000 May; 25(5):375. PubMed ID: 10795701
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
    Balachandran S; Sayle BA
    Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
    Modoni S; Martino G; Guerra M; Frusciante V
    Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
    [No Abstract]   [Full Text] [Related]  

  • 14. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
    Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma.
    Wilson LM; Barrington SF; Morrison ID; Kettle AG; O'Doherty MJ; Coakley AJ
    Eur J Nucl Med; 1998 Jun; 25(6):622-8. PubMed ID: 9618577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
    Abhyankar A; Basu S
    J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
    Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
    Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.